Literature DB >> 1717293

Parathyroid hormone fragment 1-34 inhibits drug-induced inflammation in various experimental models.

A Caruso1, M Amico-Roxas, V Cutuli, A Prato, C E Fiore, G Clementi.   

Abstract

We investigated the effect of the administration of rat parathyroid hormone-(1-34) on acute or chronic inflammatory processes in different experimental animal models. Fragment 1-34 of parathyroid hormone had an inhibitory effect in all inflammatory acute tests. The dose-response experiments showed that the maximal anti-inflammatory and anti-exudative effects appeared at the dose of 3.30 and 0.33 micrograms/kg, respectively. The anti-inflammatory effect was observed in the first phase of the inflammatory process. In the carrageenin-induced edema test the anti-inflammatory activity began to decline after 180 min. In contrast, this peptide was inactive in the inflammatory chronic test we used.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1717293     DOI: 10.1016/0014-2999(91)90565-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Delayed short-course treatment with teriparatide (PTH(1-34)) improves femoral allograft healing by enhancing intramembranous bone formation at the graft-host junction.

Authors:  Masahiko Takahata; Edward M Schwarz; Tony Chen; Regis J O'Keefe; Hani A Awad
Journal:  J Bone Miner Res       Date:  2012-01       Impact factor: 6.741

2.  Teriparatide rapidly improves pain-like behavior in ovariectomized mice in association with the downregulation of inflammatory cytokine expression.

Authors:  Takayuki Dohke; Kousuke Iba; Megumi Hanaka; Kumiko Kanaya; Shunichiro Okazaki; Toshihiko Yamashita
Journal:  J Bone Miner Metab       Date:  2017-10-05       Impact factor: 2.626

3.  Exogenous Parathyroid Hormone Alleviates Intervertebral Disc Degeneration through the Sonic Hedgehog Signalling Pathway Mediated by CREB.

Authors:  You Li; Yifan Wei; He Li; Hui Che; Dengshun Miao; Cheng Ma; Yongxin Ren
Journal:  Oxid Med Cell Longev       Date:  2022-02-27       Impact factor: 6.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.